Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof
US12234516B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2021 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Jul 31, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7028
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Described herein are methods and systems for identifying and/or treating subjects having cancer who are more likely to respond to treatment with an inhibitor of the transcription factor HIF-2α.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.